Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: skin disorder topical therapeutics - Foamix

Drug Profile

Research programme: skin disorder topical therapeutics - Foamix

Alternative Names: Benzoyl peroxide foam - Foamix; Betamethasone dipropionate foam - Foamix; Calcipotriene foam - Foamix; Calcipotriol foam - Foamix; Ciclopirox foam - Foamix; Ciclopiroxolamine foam - Foamix; Clobetasol propionate foam - Foamix; Lactic acid/urea foam - Foamix; Salicylic acid foam - Foamix; Triamcinolone acetonide foam - Foamix; U-LAC foam; UFoam; Urea foam - Foamix; Urea/lactic acid foam - Foamix

Latest Information Update: 28 Jan 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Foamix
  • Developer Foamix; Therapeutics Incorporated
  • Class Benzoic acids; Corticosteroids; Cyclohexanes; Dihydroxycholecalciferols; Fluorinated steroids; Glucocorticoids; Hydroxy acids; Indenes; Lactates; Oxidants; Pregnadienes; Pyridones; Salicylates; Small molecules; Urea compounds; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists; Cytokine inhibitors; Glucocorticoid receptor agonists; Matrix metalloproteinase inhibitors; Mitosis inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Acne; Atopic dermatitis; Dermatomycoses; Dry skin; Hyperhidrosis; Psoriasis; Seborrhoeic dermatitis

Most Recent Events

  • 28 Jan 2023 No recent reports of development identified for preclinical development in Acne in Israel (Topical, Foam)
  • 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
  • 31 Dec 2018 FCD 105 is in preclinical trials for Acne in Israel
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top